JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isobe, S.
Right arrow Articles by Narula, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isobe, S.
Right arrow Articles by Narula, J.
Journal of Nuclear Medicine Vol. 47 No. 9 1497-1505
© 2006 by Society of Nuclear Medicine


Basic Science Investigation

Noninvasive Imaging of Atherosclerotic Lesions in Apolipoprotein E–Deficient and Low-Density-Lipoprotein Receptor–Deficient Mice with Annexin A5

Satoshi Isobe1, Sotirios Tsimikas2, Jun Zhou1, Shinichiro Fujimoto1, Masayoshi Sarai1, Michael J. Branks2, Ai Fujimoto1, Leonard Hofstra3, Chris P. Reutelingsperger4, Toyoaki Murohara5, Renu Virmani6, Frank D. Kolodgie6, Navneet Narula7, Artiom Petrov1 and Jagat Narula1

1 Division of Cardiology, University of California, Irvine School of Medicine, Irvine, California; 2 Division of Cardiovascular Diseases, University of California, San Diego, La Jolla, California; 3 Department of Cardiology, Maastricht University Hospital, Maastricht, The Netherlands; 4 Division of Biochemistry, Maastricht University, Maastricht, The Netherlands; 5 Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan; 6 Armed Forces Institute of Pathology, Washington, District of Columbia; and 7 Department of Pathology, University of California, Irvine School of Medicine, Irvine, California

Correspondence: For correspondence or reprints contact: Artiom Petrov, PhD, Division of Cardiology, University of California, Irvine School of Medicine, Medical Science Building I, Room C 112, Irvine, CA 92697. E-mail: adpetrov{at}uci.edu

Transgenic mice such as apolipoprotein E–deficient (apoE–/–) and low-density-lipoprotein receptor–deficient (LDLR–/–) mice exhibit hypercholesterolemia and develop complex atherosclerotic lesions similar to those seen in humans. Radiolabeled annexin A5 has been successfully used to noninvasively image experimental and clinical atherosclerotic disease. We evaluated the feasibility of annexin A5 imaging in transgenic apoE–/– and LDLR–/– mice with or without a cholesterol diet. Methods: Thirty-three mice (mean age, 62 ± 0.9 wk old) were used. Of these 33 mice, apoE–/– mice with the cholesterol diet for 4 mo (n = 5) and without the cholesterol diet (n = 8) and LDLR–/– mice with the cholesterol diet for 6 mo (n = 7) and without the cholesterol diet (n = 7) were compared with 6 normal wild-type (C57BL/6) mice with the same genetic background. 99mTc-annexin A5 was injected in 31 animals for noninvasive imaging using micro-SPECT/CT. After in vivo micro-SPECT/CT, aortas were explanted to acquire ex vivo images and calculate the percentage injected dose per gram (%ID/g) annexin uptake, followed by histologic and immunohistochemical characterization. For the evaluation of precise target localization, biotinylated annexin A5 was injected in the remaining 2 normally fed apoE–/– mice. Results: Aortic lesions were clearly visualized noninvasively by micro-SPECT and aorta calcification was detectable by micro-CT. The quantitative uptake of annexin A5 was highest in the cholesterol-fed apoE–/– (0.88 ± 0.27 %ID/g) mice, followed by the normal chow-fed apoE–/– (0.60 ± 0.16 %ID/g), the cholesterol-fed LDLR–/– (0.59 ± 0.14 %ID/g), the chow-fed LDLR–/– (0.40 ± 0.31 %ID/g), and the control (0.15 ± 0.05 %ID/g) mice. The histologic extent of atherosclerosis paralleled radiotracer uptake, and immunohistochemical studies revealed a significant correlation between radiotracer uptake and both macrophage infiltration and the extent of apoptosis. Intravenously injected biotinylated annexin A5 localized in apoptotic and nonapoptotic macrophages. Conclusion: This study demonstrates the feasibility of noninvasive imaging of atherosclerosis with radiolabeled annexin A5 in transgenic mouse models of human atherosclerosis.

Key Words: apoE–/– mice • LDLR–/– mice • cholesterol diet • apoptosis • 99mTc-annexin A5


Related articles in JNM:

This Month in JNM

JNM 2006 47: 9a-10a. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
Y. Zhao, Y. Kuge, S. Zhao, H. W. Strauss, F. G. Blankenberg, and N. Tamaki
Prolonged High-Fat Feeding Enhances Aortic 18F-FDG and 99mTc-Annexin A5 Uptake in Apolipoprotein E-Deficient and Wild-Type C57BL/6J Mice
J. Nucl. Med., October 1, 2008; 49(10): 1707 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz
Radionuclide imaging a molecular key to the atherosclerotic plaque.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 1 - 12.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Sarai, D. Hartung, A. Petrov, J. Zhou, N. Narula, L. Hofstra, F. Kolodgie, S. Isobe, S. Fujimoto, J.-L. Vanderheyden, et al.
Broad and Specific Caspase Inhibitor-Induced Acute Repression of Apoptosis in Atherosclerotic Lesions Evaluated by Radiolabeled Annexin A5 Imaging
J. Am. Coll. Cardiol., December 11, 2007; 50(24): 2305 - 2312.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Falk, S. M. Schwartz, Z. S. Galis, and M. E. Rosenfeld
Putative Murine Models of Plaque Rupture
Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 969 - 972.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2006 by the Society of Nuclear Medicine.